Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology

Thomas Eschenhagen*, Thomas Force, Michael S. Ewer, Gilles W. De Keulenaer, Thomas M. Suter, Stefan D. Anker, Metin Avkiran, Evandro de Azambuja, Jean Luc Balligand, Dirk L. Brutsaert, Gianluigi Condorelli, Arne Hansen, Stephane Heymans, Joseph A. Hill, Emilio Hirsch, Denise Hilfiker-Kleiner, Stefan Janssens, Steven de Jong, Gitte Neubauer, Burkert PieskePiotr Ponikowski, Munir Pirmohamed, Mathias Rauchhaus, Douglas Sawyer, Peter H. Sugden, Johann Wojta, Faiez Zannad, Ajay M. Shah

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1-10
JournalEuropean journal of heart failure
Volume13
Issue number1
DOIs
Publication statusPublished - Jan 2011

Keywords

  • Cardiotoxicity
  • Cardio-oncology
  • Targeted therapy
  • Anthracyclines
  • Heart failure
  • Consensus statement

Cite this